Ureteral Stents Market

Global Ureteral Stents Market Size (2024 to 2032)

The global ureteral stents market was worth US$ 399 million in 2023 and is anticipated to reach a valuation of US$ 749 million by 2032 from US$ 428 million in 2024, and it is predicted to register a CAGR of 7.24% during the forecast period 2024-2032.

A ureteral stent is a thin tube inserted into the ureter through a small hole to cure the blockage of urine passage from the kidney. Ureteral stents are used for urological problems and are allowed to function urine flow properly. In today's industry, this process is used to restore the flow of urine blockage through the ureters and bring back the normal functioning of the kidneys. Ureteral stents are temporary, which help in holding the ureters open to allow the passage of urine to flow from the kidneys into the bladder. This is needed for people with ureteral obstructions, which obstruct urine flow into the bladder due to narrowed ureters, ureteric stones, kidney stones, or tumors. These thin, long, flexible tubes may also be placed for extended periods in the case of people with chronic conditions requiring longer-term ureteral stents. The device has two ends where one end is placed in the bladder and placed in the kidney.

MARKET DRIVERS

YOY growth in the number of patients suffering from urological diseases and the rising adoption of a sedentary lifestyle among people drive the global ureteral stents market.

The incidence of urological diseases such as urinary tract infections, kidney stones, bladder control problems, and prostate problems among people is growing significantly. An estimated 150 million cases of urinary tract infections are registered every year across the world, which costs around USD 6 billion in healthcare expenditure. In addition, according to National Kidney Foundation, one in ten people are expected to have a kidney at one point in their lives. The emergence of technological advancements in manufacturing ureteral stents, an increasing number of transplants of kidneys, and a growing senior population are majorly promoting the global ureteral stents market growth. The massive range of benefits associated with the ureteral stent is one of the major factors promoting the adoption and usage and boosting market growth. For instance, ureteral stents help treat a blocked ureter, providing an outflow path for urine when a kidney stone blocks the ureter, further helping the kidney function correctly. In addition, in Ureteral infection, stents help in providing a way to drain infected urine. 

Healthcare providers have increased the adoption of ureteral stents to treat ureteral obstructions, which might occur due to inflammatory bowel disease, ureteral stones, blood clots, tumors, and scar tissue resulting from endometriosis, and inherited conditions such as obstruction of the ureteropelvic junction, resulting in narrowing of the ureters. Thus, the ureteral stents help in allowing the urine to flow through the ureter around these obstructions, such as kidney stones, or even after the rupturing of those stones into smaller fragments, which might also prevent the typical passage of urine.

Moreover, most ureteral stents required are temporary and removed after the kidney stones are cleared, or other infections are controlled, stating the typical passage of urine. Although some people might need stents for months or years due to tumors that press on the ureters for a long time, ureteral stents provide a complete treatment for problems related to the functioning of the kidney and the entire urinary system. Also, its frequent replacement reduces the risk of complications. Thus, the global ureteral stents market is anticipated to be driven profitably over the forecast period. Growing medical tourism in developed countries is expected to accelerate the market's growth rate. In addition, the growing adoption of the minimum widespread of surgeries is likely to expand and grow the market. Ureteral stents are also used to treat patients diagnosed with prostate cancer, caused by making a small width of the ureter or making scars on the wall of the ureter.

MARKET RESTRAINTS

Less availability of healthcare professionals who can handle relevant treatment procedures and increased side effects associated with ureteral stents is expected to hamper the market's growth rate. Discomfort, traces of blood, worsened kidney pain, frequent urination, bladder spasms, bladder irritation, painful urination, and even the prevalence of urinary tract infections are some of the side effects faced by the patient after the placement of a ureteral stent. This may also arise due to blocked, ruptured, or displaced stents by the professionals or through vigorous activities by the patient himself. In addition, difficulties associated with removing the stent are further expected to restrain the global ureteral stents market.

Impact of COVID-19 on the Global Ureteral Stents Market

SARS-COV-2 is a contagious disease caused by the most recent novel coronavirus. COVID-19 has affected the market structure and led to the market and economic downfall. The Outbreak of COVID-19 has negatively impacted the Ureteral Stents market during the first half of 2020. The surge in COVID-19-detected cases has led to a nationwide Lockdown and a ban on transportation. The Ureteral stents market has a supply worldwide; the supply chain had been disrupted due to the prohibition of flights. In addition, market-concerned manufacturing activities were partially disrupted due to the workforce shortage and stringent government guidelines. However, after the uplift of the Lockdown, the market has witnessed significant growth. In addition, increased urological and kidney disorders have increased the demand for the market. Therefore, the market is anticipated to record healthy growth during the forecast period. 

REPORT COVERAGE

SEGMENTAL ANALYSIS

Global Ureteral Stents Market Analysis By Type

Based on the type, the expandable stents were one of the fastest-growing segments during the previous year. The increase in the prevalence of cardiovascular illnesses worldwide is driving sector growth. According to a recent WHO report, cardiovascular illnesses have claimed the lives of 17.5 million people worldwide, accounting for 31% of all fatalities.

On the other hand, double pigtail stent is anticipated to witness a significant share of the market. When transmural drainage of pancreatic fluid collections is performed, double pigtail stents are inserted transgastrically or transduodenal. Typically, two stents are inserted into the collection, one on each side of the wall. The benefit of preplacement is that the double-J stent has an extraction string that allows withdrawal without general anesthesia.

Global Ureteral Stents Market Analysis By Patient Sex

Based on gender, males are 2.8 times more likely to have stents than females. The recent research shows that Eighty-nine percent of the patients in the research were men, with an average age of 49.3 12.6 years. The average stenting time was 17.3 12.7 months. While the stent was in place, 29 percent of patients got a urine acidifier, 92 percent were stone formers, 60 percent had a urinary tract infection, and 25% had an increased creatinine level.

Global Ureteral Stents Market Analysis By End User

Based on the end-user, the hospital segment dominated the market growth and is projected to showcase a significant share in the market. The availability of facilities for kidney transplantation operations and hospital expertise contribute to the segment's growth. In addition, the proliferation of urological and kidney-related disorders and the introduction of technologically advanced stents for safe and effective urological treatments propel the hospital segment growth. Moreover, advancing healthcare infrastructure is augmenting market growth across the world.

Global Ureteral Stents Market Analysis By Medical Situation

Based on the medical situation, the kidney stones segment recorded the largest market share of the ureteral stents market in 2023. Over the projection period, the market is expected to have a revenue share of 36.8%. Sedentary lifestyles, such as eating behaviors contributing to urolithiasis, drive segment growth. According to the NCBI study publications, over 600,000 persons in the United States are estimated to suffer from urinary stones every year. In treating kidney stones, ureteroscopy and Ureteroenoscopy, among other procedures, require the insertion of a ureteral stent, which results in segment development.

REGIONAL ANALYSIS

Geographically, the North American ureteral stents market is expected to dominate the global ureteral stents market and accounted for a market share of 33.0% in 2023; the market is expected to maintain its domination during the forecast period. The North American regional growth is driven by adopting sedentary lifestyles, resulting in urological and kidney-related disorders such as chronic kidney disease, kidney stones, and urinary incontinence. In the regional market growth, the United States dominated the largest market share of the Ureteral Stents Market. The presence of major market players such as Boston scientific corporation, medical industries, and Coloplast are augmenting the market growth in the country. In addition, favorable reimbursement policies and support by the government are likely to uplift the market growth. Therefore, the Canadian market growth contributes slight revenue and regional market growth.

The European ureteral stents market is projected to have significant growth in the Ureteral Stents Market during the forecast period. It is owing to the advancement of healthcare infrastructure and the proliferation of kidney and urological disorders. Germany, the UK, France, Spain, and Italy are the market growth contributors in the region. The UK showed significant growth in the Ureteral Stents market in 2020. Some of the primary driving factors supporting the growth of this market include an increase in the number of kidney transplants. Germany is more likely to contribute to the regional market development due to rising awareness about advanced medical devices among the people in Germany. 

The Asia Pacific ureteral stents market has been one of the fastest-growing regions globally in the Ureteral stents market. Due to various improved healthcare infrastructures and increased knowledge about innovative medical devices, the Asian ureteral stents market is expected to develop at the fastest CAGR over the projected period. In addition, rising markets such as India and China provide enormous development potential for ureteral stent makers. The Indian Ureteral stents market is anticipated to witness a better revenue share. Increasing urological procedures, government support, and improving healthcare spending will likely increase the market growth. 

On the other hand, the region of Latin America ureteral stents market is anticipated to show a gradual growth over the forecast period due to the high prevalence of urological disorders as a result of physical inactiveness in the people due to growing lifestyle changes, along with an increase in the number of kidney related disorders, resulting in kidney transplants, which further requires the use of ureteral stents would be driving the regional market growth for ureteral stents.

The Middle East and African ureteral stents market is foreseen to show a highly profitable growth rate in the global market over the forecast period owing to factors such as high technological advances in the composition of stent materials. High focus by manufacturers for the same to provide effective treatment to the patients. Moreover, the increase in the incidence of urological diseases in the regions as a result of the colonization of microorganisms due to the adoption of a sedentary lifestyle as an ongoing trend and the growing geriatric population are other factors that would be considered responsible for massive growth in the regional market.

KEY MARKET PARTICIPANTS

Some prominent companies profiled in the report in the global ureteral stents market are C. R. Bard, Inc., Penn Medical, Cook Medical Inc., Boston Scientific Corporation, and Medline Industries, Inc.

RECENT DEVELOPMENTS

• In September 2022, UroGen Pharma Ltd. was granted permission by the FDA to use JELMYTO, which is being used by all stakeholders, hospitals, doctors, and pharmacists, especially for adult patients to treat urothelial disorders, including low-grade upper tract urothelial cancer (LG UTUC). 
• In May 2022, ProMedica introduced the new Relief stent, with support from UH Ventures, to relieve pain for millions of patients with kidney stones and other conditions causing difficulty with kidney drainage, along with offering reduced hospital costs. It has also received a 510k clearance from FDA.
• In November 2022, UroGen Pharma Ltd. declared the successful result of a retrospective multicenter study for safety testing of JELMYTO to 32 patients with upper tract urothelial carcinoma, which is declared to have a favorable safety and tolerability profile.

DETAILED SEGMENTATION OF THE GLOBAL URETERAL STENTS MARKET INCLUDED IN THIS REPORT

This research report on the ureteral stents market has been segmented and sub-segmented into the following categories.

By Type

• Expandable Stent
• Double pigtail stent (JJ Stent)

By Patient Sex

• Male
• Female

By Medical Situation

• Kidney Stones
  • Ureteroscopy
  • Ureteroenoscopy
• Kidney Failure
• Tumors

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East and Africa